SWHR COVID-19 eNews

May 22, 2020

Pharmacy Update

Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of May 21, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.

Note: There are no Food and Drug Administration (FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.

HYDROXYCHLOROQUINE AND COVID-19 PRE- AND POST-EXPOSURE PROPHYLAXIS

Hydroxychloroquine has been a hot topic for both treatment and prophylaxis of COVID-19. Please refer to the SWHR Pharmacy Update from April 22 regarding the risk of hydroxychloroquine. There are ongoing trials in both pre- and post- exposure prophylaxis in healthcare professionals with a high risk of exposure to COVID-19. At this time there is lack of evidence that it is effective . Read more →

FORECASTING FOR DFW: UTSW →

Department of Internal Medicine

Lyda Hill Department of Bioinformatics

Department of Emergency Medicine UTSW Health System Information Resources.

The slides illustrate a model of how COVID-19 is spreading across the DFW region based on real patient data received from Collin, Dallas, Denton and Tarrant counties.

SWHR COVID-19 Resource Center →

Southwestern Health Resources (SWHR) is committed to providing valuable, up-to-date information to the physicians we serve. This site offers resources and tools for you and your practice to use as you treat and communicate with your patients.

If you have questions about items in the SWHR COVID-19 News or Southwestern Health Resources, send us an email: SWHRNews@SouthwesternHealth.org →